Mkt Cap $186M
52-Week Range
Zentalis Pharmaceuticals, Inc.
Revenue breakdown: Reportable Segment (100%).
$186M
Market Cap
$27M
Revenue
-$150M
Net Income
Revenue by Segment
of this Current Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, a